Pharmaceutical Business review

Amgen Names New Chief Financial Officer

Mr Peacock is expected to take up the responsibility for Amgen’s finance and investor relations operations. Most recently, Mr Peacock has served as the CFO and administration officer at Novartis Pharmaceutical since 2005.

In Novartis, Peacock was responsible for finance, information technology, purchasing, strategic planning and mergers and acquisitions functions.

Previously, Mr Peacock was a partner at McKinsey and Company, where he was co-leader of the European corporate finance practice working in the consulting firm’s Amsterdam, Zurich and London offices. He also was a partner at Price Waterhouse in New York and London.

Mr Sharer said: “I am delighted to have a leader of Jonathan’s talent, vision and international experience join Amgen at a time when we are expanding globally.”